388 related articles for article (PubMed ID: 2999241)
1. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
2. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
Hibi T; Chan MA; Petsche D; Dosch HM
J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613
[TBL] [Abstract][Full Text] [Related]
3. Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution.
Miyawaki T; Kubagawa H; Butler JL; Cooper MD
J Immunol; 1988 Jun; 140(11):3887-92. PubMed ID: 2836502
[TBL] [Abstract][Full Text] [Related]
4. Isotype commitment of human B cells that are transformed by Epstein-Barr virus.
Miyawaki T; Butler JL; Radbruch A; Gartland GL; Cooper MD
Eur J Immunol; 1991 Jan; 21(1):215-20. PubMed ID: 1846818
[TBL] [Abstract][Full Text] [Related]
5. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
Tosato G; Blaese RM; Yarchoan R
J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
[TBL] [Abstract][Full Text] [Related]
6. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells.
Stein LD; Ledgley CJ; Sigal NH
J Immunol; 1983 Apr; 130(4):1640-5. PubMed ID: 6300231
[TBL] [Abstract][Full Text] [Related]
7. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets.
Jelinek DF; Splawski JB; Lipsky PE
J Immunol; 1986 Jan; 136(1):83-92. PubMed ID: 3484392
[TBL] [Abstract][Full Text] [Related]
8. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
Conley ME; Chan MA; Sigal NH
J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178
[TBL] [Abstract][Full Text] [Related]
9. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
Koizumi S
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
[TBL] [Abstract][Full Text] [Related]
11. Human peripheral blood B cell subpopulations: surface IgD+ cells respond to pokeweed mitogen with plasma cell differentiation.
Mudde GC; van Dam D; De Gast GC
Clin Exp Immunol; 1986 Apr; 64(1):150-7. PubMed ID: 3488148
[TBL] [Abstract][Full Text] [Related]
12. Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations.
Aman P; Gordon J; Lewin N; Nordström M; Ehlin-Henriksson B; Klein G; Carstensson A
J Immunol; 1985 Oct; 135(4):2362-7. PubMed ID: 2993411
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of B lineage cells from liver of neonatal mice: generation of immunoglobulin isotype diversity in vitro.
Calvert JE; Kim MF; Gathings WE; Cooper MD
J Immunol; 1983 Oct; 131(4):1693-7. PubMed ID: 6604750
[TBL] [Abstract][Full Text] [Related]
14. Human immunoglobulin class and IgG subclass regulation: dual action of interleukin-4.
Kotowicz K; Callard RE
Eur J Immunol; 1993 Sep; 23(9):2250-6. PubMed ID: 8396532
[TBL] [Abstract][Full Text] [Related]
15. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells.
Saiki O; Ralph P
Eur J Immunol; 1982 Jun; 12(6):506-10. PubMed ID: 6981514
[TBL] [Abstract][Full Text] [Related]
16. Limiting dilution analysis of the B cell compartment in human bone marrow.
Hibi T; Dosch HM
Eur J Immunol; 1986 Feb; 16(2):139-45. PubMed ID: 2869953
[TBL] [Abstract][Full Text] [Related]
17. In vitro regulation of IgA subclass synthesis. II. The source of IgA2 plasma cells.
Conley ME; Bartelt MS
J Immunol; 1984 Nov; 133(5):2312-6. PubMed ID: 6332844
[TBL] [Abstract][Full Text] [Related]
18. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
Straub C; Zubler RH
J Immunol; 1989 Jan; 142(1):87-93. PubMed ID: 2535862
[TBL] [Abstract][Full Text] [Related]
19. B cell lines from a subset of patients with common variable immunodeficiency undergo enhanced apoptosis associated with an increased display of CD95 (Apo-1/fas), diminished CD38 expression, and decreased IgG and IgA production.
Guo BC; Saxon A
Cell Immunol; 1995 Nov; 166(1):83-92. PubMed ID: 7585984
[TBL] [Abstract][Full Text] [Related]
20. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
